Publications by authors named "Tsuruta N"

Article Synopsis
  • Clinical trials often leave out elderly patients, leading to limited safety and efficacy data for biologics in this demographic.
  • A study comparing elderly (≥65 years) and younger (<65 years) patients using data from the West Japan Psoriasis Registry found that treatment-ending adverse events were more common in the elderly, and malignant neoplasms occurred at higher rates.
  • Despite some safety concerns, biologics were effective for both age groups, with no significant differences in treatment outcomes or quality of life indicators between the elderly and younger patients.
View Article and Find Full Text PDF
Article Synopsis
  • Systemic treatments for moderate-to-severe psoriasis can lead to cutaneous infections, although the specific risks of these infections are not well documented.
  • In a study involving 878 psoriasis patients treated with biologics, the incidence of cutaneous bacterial, viral, and fungal infections was analyzed, revealing low but significant rates for each type.
  • The findings indicated that specific treatments, such as tumor necrosis factor-α and interleukin-17 inhibitors, are linked to higher risks of bacterial and fungal infections, respectively, highlighting the need for careful monitoring by dermatologists.
View Article and Find Full Text PDF

Recent practice guidelines strongly recommend evidence-based psychotherapies (EBPs) as the first-line treatment for post-traumatic stress disorder (PTSD). However, previous studies found barriers to the implementation of EBPs and a relatively high dropout rate in clinical settings. After proving the efficacy of prolonged exposure (PE) in Japan [Asukai, N.

View Article and Find Full Text PDF

The cancer stem cell (CSC) theory features typically rare self-renewing subpopulations that reconstitute the heterogeneous tumor. Identification of molecules that characterize the features of CSCs is a key imperative for further understanding tumor heterogeneity and for the development of novel therapeutic strategies. However, the use of conventional markers of CSCs is still insufficient for the isolation of bona fide CSCs.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed data from 1003 psoriasis patients treated at 20 facilities in Western Japan, focusing on the survival rates of various systemic treatments, including biologics and traditional drugs, from 2010 onward.
  • * Recently released interleukin 17 inhibitors had higher survival rates overall, but the differences were less pronounced for patients starting treatment after 2017; factors like obesity and coexisting psoriatic arthritis were linked to worse drug survival rates, while no significant safety concerns were reported
View Article and Find Full Text PDF
Article Synopsis
  • - A study from the West Japan Psoriasis Registry examined 1847 psoriasis patients and found that 10.8% had a family history of the condition, which correlated with an earlier onset and longer duration of the disease.
  • - Patients with a family history of psoriasis were more likely to develop psoriatic arthritis (PsA), with a higher percentage (34.7%) compared to those without a family history (26.6%).
  • - The research suggests that genetics play a significant role in the development of PsA, indicating that dermatologists should pay closer attention to joint symptoms in patients with psoriasis who have a family history of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • The study compares the efficacy and toxicity of the original FOLFIRINOX (oFFX) and a modified version (mFFX) for treating metastatic pancreatic cancer (mPC) in a Japanese patient population.
  • A multicenter analysis of 318 patients revealed no significant difference in overall survival and progression-free survival between oFFX and mFFX, although oFFX had higher rates of thromobocytopenia and liver dysfunction.
  • The findings suggest that mFFX is as effective as oFFX while causing fewer side effects, making it a safer option in clinical practice.
View Article and Find Full Text PDF

Generalized pustular psoriasis (GPP) is a rare and severe subtype of psoriasis. Because of its rarity, GPP studies with a large sample size have been scarce. We studied the characteristics of GPP and pustular psoriasis using data from the West Japan Psoriasis Registry that had been registered until the end of December 2020.

View Article and Find Full Text PDF

We describe a case of pulmonary tumor embolism (PTE) from breast cancer diagnosed by selective aspiration cytology using a Swan-Ganz catheter. A 60-year-old woman was referred to Hamanomachi Hospital because of increased levels of tumor markers. The patient complained only of slight exertional dyspnea and a dry cough.

View Article and Find Full Text PDF

The efficacy and safety of new psoriatic treatments are confirmed in clinical trials, but such clinical trial data are limited by the number and heterogeneity of patients. Furthermore, the prevalence and characteristics of psoriasis differ among racial groups. Therefore, it is important to obtain real-world evidence in specific regions.

View Article and Find Full Text PDF

Drug-induced immune thrombocytopenia (DITP) is an important cause of thrombocytopenia. A 73-year-old man with relapsed rectal carcinoma received S-1, oxaliplatin and bevacizumab combination therapy (SOX+Bev). Dexamethasone was administered as an antiemetic prophylaxis.

View Article and Find Full Text PDF

Fat mass and obesity-associated protein (FTO) is an enzyme that demethylates N6-methyladenosine (mA), the most abundant RNA modifications in a cell. The upregulated expression of FTO promotes the progression of various types of cancer by modulating cell-intrinsic genes which relate to malignant potential. However, the impact of FTO on the expression of immune-checkpoint molecules in the tumor cells, which are important for immune escape, has not been well understood.

View Article and Find Full Text PDF

Although rare, tuberculosis has been reported with biologic treatment against psoriasis in Japan, a tuberculosis medium-burden country. Mycobacterial infection often develops after a long incubation period and might not have been adequately identified in clinical trials or post-marketing surveillance. To determine the real-world incidence of tuberculosis in psoriatic patients treated with biologics, we conducted a retrospective, multicenter, observational study in 18 facilities in Western Japan.

View Article and Find Full Text PDF

Psoriatic arthritis (PsA) is an inflammatory arthritis with as yet unclear pathophysiology. This retrospective, multicenter, cross-sectional study was conducted in 19 facilities in western Japan and aimed to identify patients' characteristics and factors that affect the results of treatment with biologic agents. Of 2116 patients with psoriasis, 285 (13.

View Article and Find Full Text PDF

The liquid biopsy of ascites fluid could be an excellent source of tumor and microenvironment for the study of prognostic biomarkers because of its accessibility. Tumor-infiltrating lymphocytes (TILs) can predict prognosis in multiple malignancies, including the response to immune checkpoint inhibitors, a breakthrough cancer therapy. However, TILs' profiles from malignant ascites have not been extensively studied.

View Article and Find Full Text PDF

The efficacy and safety of immune-checkpoint inhibitors in non-small cell lung cancer patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Herein, we describe the case of a 62-year-old man with multiple pleural tumors and carcinomatous pleurisy. High-resolution computed tomography indicated usual interstitial pneumonia, and a respiratory function test revealed a restrictive disorder and decreased diffusion capacity.

View Article and Find Full Text PDF

Disseminated cancer cells in malignant ascites possess unique properties that differ from primary tumors. However, the biological features of ascites tumor cells (ATC) have not been fully investigated. By analyzing ascites fluid from 65 gastrointestinal cancer patients, the distinguishing characteristics of ATC were identified.

View Article and Find Full Text PDF

Rationale: Metastatic littoral cell angioma (LCA) is extremely rare. No standard therapeutic strategy has been established, and the impact of chemotherapy has not yet been evaluated.

Patient Concerns: A 61-year-old woman was admitted because of bicytopenia.

View Article and Find Full Text PDF

The patient was a 54-year-old woman with anaplastic lymphoma kinase-positive stage III B lung cancer. She received 4 courses of carboplatin(CBDCA)plus paclitaxel(PTX)plus bevacizumab(Bev)chemotherapy and crizotinib. Chemotherapy reduced the size of the primary site and mediastinal lymphadenopathy; however, the right supraclavicular and subcarinal lymph nodes were enlarged again during crizotinib treatment.

View Article and Find Full Text PDF

Purpose: Diarrhea and oral mucositis induced by afatinib can cause devastating quality of life issues for patients undergoing afatinib treatment. Several studies have shown that hangeshashin-to (TJ-14) might be useful for chemotherapy-induced diarrhea and oral mucositis. In this study, we investigated the prophylactic effects of TJ-14 for afatinib-induced diarrhea and oral mucositis and minocycline for afatinib-induced skin rash.

View Article and Find Full Text PDF

The T790M secondary mutation of the epidermal growth factor receptor (EGFR) gene accounts for 50% to 60% of cases of resistance to the first-generation EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib. The prevalence of T790M in mutation-positive patients who acquire resistance to the irreversible, second-generation EGFR-TKI afatinib has remained unclear, however. We here determined the frequency of T790M acquisition at diagnosis of progressive disease in patients with -mutated non-small cell lung cancer (NSCLC) treated with afatinib as first-line EGFR-TKI.

View Article and Find Full Text PDF

An advanced granulocyte-colony stimulating factor (G-CSF)-producing tumor is rare, and it exhibits leukocytosis in association with high serum G-CSF levels. A 67-year-old male with a 1-month history of bloody emesis and black stools was revealed to exhibit leukocytosis, anemia and a high serum concentration of G-CSF. During a gastrointestinal endoscopy, an ulcerating tumor was identified in the stomach.

View Article and Find Full Text PDF